Age-related loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
European rare disease database
Common questions about age-related macular degeneration
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning age-related macular degeneration
Updated Feb 10, 2026
NIH scientists have developed a 'digital twin' model of eye cells to better understand age-related macular degeneration, the leading cause of vision loss. This breakthrough technology reveals how cellular organization deteriorates, potentially paving the way for new treatment strategies.